UTAH MEDICAL PRODUCTS, INC. Available-for-sale Securities, Gross Unrealized Gain (Loss) (Deprecated 2013-01-31)
UTAH MEDICAL PRODUCTS, INC. (UTMD) had Available-for-sale Securities, Gross Unrealized Gain (Loss) (Deprecated 2013-01-31) of $2.00 thousand as of 2014-12-31, per its 10-K filed 2015-03-12.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesGrossUnrealizedGainLoss · last filed 2015-03-12
- 2014-12-31: Available-for-sale Securities, Gross Unrealized Gain (Loss) (Deprecated 2013-01-31) $2.00K.
- 2013-12-31: Available-for-sale Securities, Gross Unrealized Gain (Loss) (Deprecated 2013-01-31) $14.00K.
- 2013-03-31: Available-for-sale Securities, Gross Unrealized Gain (Loss) (Deprecated 2013-01-31) $5.00K.
- 2012-12-31: Available-for-sale Securities, Gross Unrealized Gain (Loss) (Deprecated 2013-01-31) $14.00K.
| Period end | Available-for-sale Securities, Gross Unrealized Gain (Loss) (Deprecated 2013-01-31) |
|---|---|
| 2014-12-31 | $2.00K 10-K · filed 2015-03-12 |
| 2013-12-31 | $14.00K 10-K · filed 2015-03-12 |
| 2013-03-31 | $5.00K 10-Q · filed 2013-05-08 |
| 2012-12-31 | $14.00K 10-K · filed 2014-03-12 |
| 2012-09-30 | $8.00K 10-Q · filed 2012-11-09 |
| 2012-06-30 | -$8.00K 10-Q · filed 2012-08-08 |
| 2012-03-31 | $15.00K 10-Q · filed 2013-05-08 |
| 2011-12-31 | -$23.00K 10-K · filed 2013-03-07 |
| 2011-09-30 | -$25.00K 10-Q · filed 2012-11-09 |
| 2011-06-30 | -$5.00K 10-Q · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |